The Carlyle Group Top Holdings and 13F Report (2022) → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) About The Carlyle GroupThe Carlyle Group NASDAQ: CG has filed 13-F forms with the SEC as an investor. The Carlyle Group is itself a publicly traded company. For more information on The Carlyle Group stock, visit the The Carlyle Group stock profile here.Investment ActivityThe Carlyle Group has $2.08 billion in total holdings as of September 30, 2022.The Carlyle Group owns shares of 25 different stocks, but just 3 companies or ETFs make up 80% of its holdings.Approximately 1.12% of the portfolio was purchased this quarter.About 15.59% of the portfolio was sold this quarter.This quarter, The Carlyle Group has purchased 25 new stocks and bought additional shares in 2 stocks.The Carlyle Group sold shares of 2 stocks and completely divested from 1 stock this quarter.Largest Holdings QuidelOrtho $918,315,487ZoomInfo Technologies $651,670,324Soleno Therapeutics $115,038,749Vitru $98,444,383Getty Images $49,320,175 Largest New Holdings this Quarter Spyre Therapeutics Inc $203,944 Holding Largest Purchases this Quarter Soleno Therapeutics 564,242 shares (about $22.71M)Complete Solaria Inc 250,000 shares (about $387.50K)Spyre Therapeutics Inc 9,620 shares (about $203.94K) Largest Sales this Quarter ZoomInfo Technologies 1,132,819 shares (about $20.95M)Getty Images 327,927 shares (about $1.72M) Sector Allocation Over TimeMap of 500 Largest Holdings ofThe Carlyle Group Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorQDELQuidelOrtho$918,315,4870.0%12,460,18344.2%MedicalZIZoomInfo Technologies$651,670,324$20,945,823 ▼-3.1%35,244,47431.3%Computer and TechnologySLNOSoleno Therapeutics$115,038,749$22,713,137 ▲24.6%2,857,8045.5%MedicalVTRUVitru$98,444,3830.0%6,246,4714.7%Consumer DiscretionaryGETYGetty Images$49,320,175$1,721,617 ▼-3.4%9,394,3192.4%Computer and TechnologyVRNAVerona Pharma$48,805,9500.0%2,457,5002.3%MedicalGDSGDS$37,142,3340.0%4,072,6241.8%Business ServicesPHATPhathom Pharmaceuticals$31,925,8570.0%3,496,8081.5%MedicalHLVXHilleVax$29,507,7000.0%1,838,4861.4%MedicalVERAVera Therapeutics$22,104,4420.0%1,438,1551.1%MedicalSMHISEACOR Marine$16,545,3250.0%1,314,1640.8%TransportationINVHInvitation Homes$16,287,5250.0%477,5000.8%FinanceCUBECubeSmart$10,220,1750.0%220,5000.5%FinanceSPRBSpruce Biosciences$8,370,9370.0%2,896,5180.4%MedicalJSPRJasper Therapeutics$6,669,5510.0%8,761,8910.3%MedicalRPHMReneo Pharmaceuticals$4,318,3310.0%2,698,9570.2%MedicalComplete Solaria Inc$4,256,112$387,500 ▲10.0%2,745,8790.2%ComACETAdicet Bio$3,976,9240.0%2,115,3850.2%MedicalEMSmart Share Global$2,409,9140.0%4,810,2090.1%Consumer DiscretionaryEFTReFFECTOR Therapeutics$2,228,7810.0%4,822,1140.1%MedicalNCNANuCana$967,0000.0%3,333,3330.0%MedicalAIUMeta Data$306,0060.0%314,4000.0%Industrial ProductsSpyre Therapeutics Inc$203,944$203,944 ▲New Holding9,6200.0%Com NewXCURExicure$163,4050.0%281,6360.0%MedicalMolecular Templates Inc$49,3320.0%13,3330.0%Com NewMKSIMKS Instruments$0$301,395,628 ▼-100.0%00.0%Computer and TechnologyShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
